Vicore Pharma Ab

This study tests a new oral drug called buloxibutid in 378 adults with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. Over 52 weeks, researchers compare two doses of the drug against a placebo to see if it helps maintain lung functio…